You have received this email because you previously registered with the NHS COVID-19 vaccine research registry.
A new COVID-19 vaccine study is starting and looking for healthy adult volunteers to participate, who haven’t yet had a COVID vaccine. The study is sponsored by Valneva Austria GmbH. The major eligibility criteria are as follows:
• Aged 18 years or older
• Generally healthy
• Not already received or have booked to receive a vaccination intended to prevent COVID-19
If you have received an approved vaccine as part of the national rollout then you will NOT be eligible to participate in this trial. If you have been offered the vaccine but was unable to take it or have not yet been offered an approved vaccine then we encourage you to continue on to our pre-screening programme below. If you take part in this study, and are under 30 years of age you will be assigned to receive the VLA2001 vaccine.
If you are 30 years of age and over, you will be randomly assigned to receive either the investigational vaccine or the AstraZeneca vaccine, which is currently being administered throughout the UK as part of the national vaccine roll out. There is a two in three chance you will receive the investigational vaccine and a one in three chance you will receive the AstraZeneca vaccine.
There will be no cost to you, and you will be reimbursed for your time and inconvenience.
There will be a screening visit, two vaccination visits four weeks apart, and up to five further visits to attend. Study related activities will include physical examinations, COVID-19 testing and blood samples. In total, your participation is required for about 13 months.
Find out if you qualify by visiting our pre-screening website at
Pre-screening Questionnaire. This service is provided by Pharm-Olam, a commercial clinical trial company.
You may be reimbursed for reasonable travel costs during your participation. Please note that travel to research or other healthcare appointments is considered essential travel at this time of extra COVID restrictions, and that your appointment will take place in a COVID-safe environment.
This study is being run with the support of the NHS and the National Institute for Health Research, working in partnership with Valneva Austria GmbH, Pharm-Olam and Panthera.
As a COVID-19 vaccine has been approved and roll out has started in the UK during the course of this study, we have put in place a process to make sure people on this trial are not disadvantaged. It is important to note that we will ideally find several vaccines to protect the whole population. Your participation in this study is still very much needed. More information can be found at
www.bepartofresearch.org.uk.
As a registered volunteer with the NHS COVID-19 vaccine research registry, you may have received a request to join this or another vaccine study before, and we may send you further invitations. If you haven't already applied through this link, we are still looking for volunteers like you. However, you cannot take part (meaning to receive a trial vaccine) in more than one vaccine study.
Thank you for your ongoing participation in the NHS COVID-19 Vaccine Research Register. If you no longer wish to be part of this service, you can withdraw your permission at any time please visit
Sign up to be contacted for coronavirus vaccine studies.
Professor Adam Finn, MD, PhD
Chief Invesitgator
(sic)